腎臓移植治療法の世界市場2019-2023...市場調査レポートについてご紹介

【英文タイトル】Kidney Transplantation Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Selective cytokine inhibitors – Market size and forecast 2018-2023
• Immunosuppressive antimetabolites – Market size and forecast 2018-2023
• Other drugs – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Novel techniques for kidney transplantation
• Reimbursement policies for kidney transplantation
• Increasing strategic alliances
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Astellas Pharma, Inc.
• F. Hoffmann-La Roche Ltd.
• Mylan NV
• Novartis AG
• Veloxis Pharmaceuticals A/S
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO

Exhibit 01: Vendors: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Selective cytokine inhibitors – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Selective cytokine inhibitors – Year-over-year growth 2019-2023 (%)
Exhibit 22: Immunosuppressive antimetabolites – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Immunosuppressive antimetabolites – Year-over-year growth 2019-2023 (%)
Exhibit 24: Other drugs – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Other drugs – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America – Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Astellas Pharma Inc. – Vendor overview
Exhibit 51: Astellas Pharma Inc. – Business segments
Exhibit 52: Astellas Pharma Inc. – Organizational developments
Exhibit 53: Astellas Pharma Inc. – Geographic focus
Exhibit 54: Astellas Pharma Inc. – Key offerings
Exhibit 55: Astellas Pharma Inc. – Key customers
Exhibit 56: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 57: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 58: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 59: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 60: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 61: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 62: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 63: Mylan NV – Vendor overview
Exhibit 64: Mylan NV – Product segments
Exhibit 65: Mylan NV – Organizational developments
Exhibit 66: Mylan NV – Geographic focus
Exhibit 67: Mylan NV – Segment focus
Exhibit 68: Mylan NV – Key offerings
Exhibit 69: Mylan NV – Key customers
Exhibit 70: Novartis AG – Vendor overview
Exhibit 71: Novartis AG – Business segments
Exhibit 72: Novartis AG – Organizational developments
Exhibit 73: Novartis AG – Geographic focus
Exhibit 74: Novartis AG – Segment focus
Exhibit 75: Novartis AG – Key offerings
Exhibit 76: Novartis AG – Key customers
Exhibit 77: Veloxis Pharmaceuticals A/S – Vendor overview
Exhibit 78: Veloxis Pharmaceuticals A/S – Business segments
Exhibit 79: Veloxis Pharmaceuticals A/S – Organizational developments
Exhibit 80: Veloxis Pharmaceuticals A/S – Geographic focus
Exhibit 81: Veloxis Pharmaceuticals A/S – Key offerings
Exhibit 82: Veloxis Pharmaceuticals A/S – Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of market positioning of vendors


【レポート販売概要】

■ タイトル:腎臓移植治療法の世界市場2019-2023
■ 英文:Kidney Transplantation Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日:2019年8月28日
■ 調査会社:Technavio
■ 商品コード:IRTNTR31945
■ 調査対象地域:グローバル、アジア太平洋、ヨーロッパ、北米、その他
  • 世界主要国におけるサイクロスポーラ検査市場2015
    The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Co …
  • 世界のナノコンポジット市場:クレイ系、カーボンナノチューブ系
    About Nanocomposites Nanocomposites are a class of materials, which incorporate nano-sized particles in a matrix of other materials such as polymers. Such nano-sized particles enhance the properties of the matrix material, including characteristics such as mechanical strength, electrical and thermal conductivity, and chemical resistance. Nanocomposites are used in a range of industries such as Bui …
  • 自動車用高性能サスペンションシステムの世界市場2019-2023
    114 pages, November 2018 About this market The integration of active steering controls within performance suspension systems will drive growth in the market. Vehicle makers are upgrading their existing vehicular system with digital systems to increase operational efficiency and safety. Technavio’s analysts have predicted that the automotive performance suspension market will register a CAGR of alm …
  • 天気予報サービスの世界市場展望2017-2026
    According to Stratistics MRC, the Global Weather Forecasting Services market is accounted for $1.22 billion in 2017 and is expected to reach $2.68 billion by 2026 growing at a CAGR of 9.1% during the forecast period. Growing security concern with end-use industry, enlarge in air travel, expansion of transport manufacturing, and improbability in rainfall are some of the key factors which are drivin …
  • サードパーティ・バンキング・ソフトウェアの世界市場
    About Third-party Banking Software A third-party software vendor, unlike the legacy system that is developed by a bank’s own in-house IT staff, develops third-party banking software. Worldwide banks are increasingly becoming dissatisfied with legacy systems. These systems lack innovative functionalities available in the modern systems today. Integration of new functionalities in a legacy system is …
  • スカンジウムの世界市場
    Scandium (CAS 7440-20-2) Market Research Report 2014 presents comprehensive data on scandium markets globally and regionally (Europe, Asia, North America etc.) The report includes scandium description, covers its application areas and related patterns. It overviews scandium market, names scandium producers and indicates its suppliers. Besides, the report provides scandium prices in regional market …
  • ハイスループットスクリーニングの世界市場予測(~ 2021):細胞アッセイ、ラボオンチップ、バイオインフォマティクス、ウルトラハイスループットスクリーニング、ラベルフリー技術
    The global high-throughput screening (HTS) market is projected to reach USD 18.83 Billion by 2021, at a CAGR of 7.8% from 2016 to 2021. The market growth can be attributed to a number of factors such as growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising go …
  • 世界のEV走行用モータ市場2015
    The Global EV Traction Motor Industry Report 2015 is a professional and in-depth study on the current state of the EV Traction Motor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The EV Traction Motor market analysis is provided for the international markets including development trends, competitive …
  • 世界のB型肝炎ワクチン市場(2014-2018)
    About Hepatitis B Vaccines Hepatitis B is an inflammatory condition that occurs due to infection by hepatitis B virus. Hepatitis B virus is an enveloped virus that belongs to the family of hepadnavirus. It contains a circular genome with partially double-stranded DNA. The virus interferes with the normal functioning of the liver cells. Following the viral infection, the immune system is activated …
  • 鼻咽腔癌:グローバル臨床試験レビュー(2014年上半期)
    Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and the …
  • 太陽光発電インバーターの世界市場:ストリングインバーター、セントラルインバーター、マイクロインバーター
    About solar PV inverters A PV inverter is a device that converts direct current from solar panels into alternate current of the required frequency, which is then supplied to the electric grid. This device uses the maximum power point tracking (MPPT) technique to extract the maximum amount of power from an array of solar panels. Though it functions just as a simple converter, a PV inverter is the m …
  • ポリオールの世界市場:ポリエーテルポリオール、ポリエステルポリオール
    The report on polyols captures its market size by its volume and value. The polyols market is growing with a moderate rate in Asia-Pacific and RoW. The demand for polyols is driven by the following factors: • Rapidly growth in construction activities and a growing automotive industry in Asia-Pacific is attributing to the growing demand for polyols. The demand of polyols in Asia-Pacific for the las …
  • 2014年戦略提言:イタリアの治療薬物モニタリング(TDM)市場
    This new 247-page report from Venture Planning Group provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.  The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carb …
  • 後発性希少血液疾患治療薬の世界市場:PNH、ITP、PV、MF、MDS
    About Acquired Orphan Blood Diseases Therapeutics Acquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically because of the improper functioning of bone marrow to produce RBCs in the blood. This leads to a decrease in platelet counts, which can eventually lead to anemia and thrombosis. The acquired orpha …
  • 光ファイバーセンサの世界市場2016-2020
    Technavio market research analyst predicts the global fiber optic sensors market to grow steadily at a CAGR of about 9% during the forecast period. The fiber optic sensors capability of a higher tolerance for high temperatures is expected to drive the demand for these sensors in applications that has extreme environmental conditions and where electrical sensors fail to function properly, such as t …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。